Codexis (CDXS) Receivables - Net (2010 - 2026)
Codexis (CDXS) posted quarterly Receivables - Net of $8.0 million for Q1 2026, down 30.72% year-over-year from $11.6 million in Q1 2025, and down 24.88% quarter-over-quarter from $10.7 million in Q4 2025.
Codexis (CDXS) Receivables - Net (2010 - 2026) Analysis & Trends
Codexis' Receivables - Net history runs 17 years deep, the most recent figure standing at $8.0 million for Q1 2026.
- In Q1 2026, Receivables - Net fell 30.72% year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $8.0 million (down 30.72% YoY), while the FY2025 annual figure was $10.7 million, down 43.41% from the prior year.
- Receivables - Net for Q1 2026 stood at $8.0 million, down from $10.7 million in the prior quarter.
- The five-year high for Receivables - Net was $48.9 million in Q2 2022, with the low at $6.2 million in Q1 2024.
- The 5-year median for Receivables - Net is $12.4 million (2024), against an average of $16.9 million.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net soared 151.03% in 2022, then plunged 82.0% in 2023.
- Codexis' Receivables - Net stood at $31.9 million in 2022, then plunged by 37.54% to $19.9 million in 2023, then declined by 5.24% to $18.9 million in 2024, then tumbled by 43.41% to $10.7 million in 2025, then slipped by 24.88% to $8.0 million in 2026.
- Business Quant data shows CDXS's Receivables - Net at $8.0 million in Q1 2026, $10.7 million in Q4 2025, and $9.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - |
| 10 | Codexis | 144.77 Mn | 89.86 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.65 Mn |
| Jun 30, 2026 | 11.65 Mn |
| Mar 31, 2026 | 8.03 Mn |
| Mar 31, 2026 | 8.03 Mn |
| Dec 31, 2025 | 10.69 Mn |
| Dec 31, 2025 | 10.69 Mn |
| Sep 30, 2025 | 9.73 Mn |
| Sep 30, 2025 | 9.73 Mn |
| Jun 30, 2025 | 12.27 Mn |
| Jun 30, 2025 | 12.27 Mn |
| Mar 31, 2025 | 11.59 Mn |
| Mar 31, 2025 | 11.59 Mn |
| Dec 31, 2024 | 18.88 Mn |
| Dec 31, 2024 | 18.88 Mn |
| Sep 30, 2024 | 16.54 Mn |
| Sep 30, 2024 | 16.54 Mn |
| Jun 30, 2024 | 12.39 Mn |
| Jun 30, 2024 | 12.39 Mn |
| Mar 31, 2024 | 6.24 Mn |
| Mar 31, 2024 | 6.24 Mn |